Andrea Towlerton

Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide

Christopher G. Kanakry, David G. Coffey, Andrea Towlerton et al. · JCI Insight · 2016 · 142 citations · Full text

A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure

Amer M. Zeidan, Hanna A. Knaus, Tara M. Robinson et al. · Clinical Cancer Research · 2018 · 94 citations · Full text

Epigenetic Modulation to Enable Antigen-specific T-cell Therapy of Colorectal Cancer

Jeffrey Chou, Lilien N. Voong, Christie Mortales et al. · Journal of Immunotherapy · 2012 · 48 citations · Full text

Phenotypic and Transcriptional Fidelity of Patient-Derived Colon Cancer Xenografts in Immune-Deficient Mice

Jeffrey Chou, Matthew Fitzgibbon, Christie Mortales et al. · PLoS ONE · 2013 · 40 citations · Full text

Immune-deficient Mice, Immunology, Crc Cells +16

Immune escape from NY-ESO-1-specific T-cell therapy via loss of heterozygosity in the MHC

Zandra Klippel, Jeffrey Chou, Andrea Towlerton et al. · Gene Therapy · 2014 · 38 citations · Full text

Autoimmune Disease, Ny-eso-1-specific T-cell Therapy, Medicine +10